Extraordinary Shareholder Meeting
21.05.2026
See also
Synektik one step closer to planned division
- Corporate news
- Investor relations
KNF has approved the Syn2bio prospectus. The debut on the WSE is planned for April
- Corporate news
- Investor relations
Synektik edges closer to demerger as Syn2bio files prospectus with KNF
- Corporate news
- Investor relations